The Philippine Pharmaceutical and Healthcare Association (PHAP) on Tuesday cautioned that pharmaceutical companies will reduce their labor force as a result of potential loss of competitiveness due to the high retail price recently levied on certain medicines. PHAP’s opposition to price control has been consistent since global experience showed that artificial measures lead to market inefficiencies and lack of supply …